By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The stocks of many players in the genomics tools field rose yesterday following Roche's $5.7 billion hostile takeover bid for Illumina.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: caution urged in use of gene drives, and more.
NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.
PLOS Biology has asked researchers how they envision the future of genetics and genomics.
Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."